ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2558

Dissociation of the Inhibitory Apoptosis Stimulating Protein of p53 (iASPP) Binding with Transcription Factor p73 Induces Synovial Fibroblast Apoptosis in the Rheumatoid Joint

Chrong-Reen Wang1, Shih-Yao Chen1, Ai-Li Shiau2, Ming-Fei Liu1 and Chao-Liang Wu3, 1Internal Medicine, National Cheng Kung University Medical College and Hospital, Tainan, Taiwan, 2Microbiology and Immunology, National Cheng Kung University Medical College, Tainan, Taiwan, 3Biochemistry and Molecular Biology, National Cheng Kung University Medical College, Tainan, Taiwan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Apoptosis, pathogenesis, rheumatoid arthritis, synovial cells, synovial fluid and transcription factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Apoptosis-resistant synovial fibroblasts (SFs) constitute the major cell component of pannus tissues in rheumatoid arthritis (RA). In tumor cells, the binding of inhibitory apoptosis stimulating protein of p53 (iASPP) with transcription factor p53 family members can inhibit the downstream apoptosis signaling. We hypothesized that iASPP molecule is involved in the RA pathogenesis, and examined whether dissociation of such binding can induce SFs apoptosis in the rheumatoid joint.

Methods: Peripheral mononuclear cells (MNCs) from active RA before and after a TNF inhibitor therapy and osteoarthritis (OA) patients were examined for their iASPP expression by real-time RT-PCR. Synovial tissues and purified SFs from RA and OA patients as well as normal and collagen-induced arthritis (CIA) rats were subjected to immunohistochemical (IHC) and immunofluorescent staining for the expression of iASPP and p73, a member of p53 family. SFs transfected with adenoviral vectors encoding 37 amino acid (Ad37AA), a hybrid small peptide corresponding to p53 residues, were subjected to TUNEL assay and real-time RT-PCR for apoptotic status and the expression of p53 upregulated modulator of apoptosis (PUMA), respectively. The association of iASPP with p73 in Ad37AA-transfected SFs was identified by anti-iASPP immunoprecipitation, followed by anti-p73 immunoblotting assay. Therapeutic effects of intra-articular injection of Ad37AA on CIA joints were evaluated by articular index and histological score. Further synovial IHC staining was performed to analyze PUMA and IL-6 expression levels and SFs densities, and in situ apoptotic cells in synovial tissues were detected by the TUNEL assay.

Results: There were reduced iASPP levels by targeting TNF in MNCs from RA patients and increased iASPP levels with co-localized p73 expression in synovial tissues and purified SFs from RA patients and CIA rats. Enhanced cell apoptosis and increased PUMA expression were identified in Ad37AA-transfected SFs with lower iASPP-associated p73 levels. Articular indexes and histologic scores were reduced in Ad37AA-injected CIA joints with decreased SF densities, increased apoptotic cells, higher PUMA and lower IL-6 expression levels.

Conclusion:   Our results demonstrate a pathogenic role of TNF-mediated up-regulation of iASPP and induction of SFs apoptosis by dissociating the iASPP binding with transcription factor p73 in the rheumatoid joint, implicating iASPP as a potential therapeutic target molecule in RA patients.


Disclosure: C. R. Wang, None; S. Y. Chen, None; A. L. Shiau, None; M. F. Liu, None; C. L. Wu, None.

To cite this abstract in AMA style:

Wang CR, Chen SY, Shiau AL, Liu MF, Wu CL. Dissociation of the Inhibitory Apoptosis Stimulating Protein of p53 (iASPP) Binding with Transcription Factor p73 Induces Synovial Fibroblast Apoptosis in the Rheumatoid Joint [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/dissociation-of-the-inhibitory-apoptosis-stimulating-protein-of-p53-iaspp-binding-with-transcription-factor-p73-induces-synovial-fibroblast-apoptosis-in-the-rheumatoid-joint/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dissociation-of-the-inhibitory-apoptosis-stimulating-protein-of-p53-iaspp-binding-with-transcription-factor-p73-induces-synovial-fibroblast-apoptosis-in-the-rheumatoid-joint/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology